Mulligan Richard
CIK 0001376247
Head of SanaXDirector
Filings
16
Latest May 4, 2026
Issuers covered
4
Showing
16 of 16
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 50% | +3.4% | +3.4% | +6.8% | 0.0% |
| 90 days | 2 | 100% | +56.8% | +56.8% | +60.1% | +53.5% |
| 180 days | 2 | 100% | +38.2% | +38.2% | +40.8% | +35.6% |
| 365 days | 2 | 100% | +13.2% | +13.2% | +16.6% | +9.8% |
Issuers
Companies where Mulligan Richard has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| BHC | Bausch Health Companies Inc. | 6 | May 20, 2025 |
| SANA | Sana Biotechnology, Inc. | 6 | Jun 9, 2025 |
| IFF | International Flavors & Fragrances Inc | 3 | May 4, 2026 |
| BIIB | Biogen Inc. | 1 | Jun 17, 2022 |
All filings
16 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|